Subsys Alternatives Compared
| Subsys | Fentanyl | Actiq |
|
|---|
| Subsys (fentanyl) | Fentanyl | Actiq (fentanyl) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Chronic Pain, Breakthrough Pain. Subsys may also be used for purposes not listed in this medication guide. |
Prescription only
Fentanyl is a very potent pain-relieving medicine. It is not recommended for people who have never been prescribed opioid-type pain relief before, and deaths have been reported from improper dosing... View more |
Prescription only
Prescribed for Chronic Pain, Breakthrough Pain, Pain. Actiq may also be used for purposes not listed in this medication guide. |
||||||||||||||||
| More about Subsys (fentanyl) | More about Fentanyl | More about Actiq (fentanyl) | ||||||||||||||||
| Generic Status | ||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Subsys has an average rating of 8.6 out of 10 from a total of 12 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Fentanyl has an average rating of 7.8 out of 10 from a total of 423 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 11% reported a negative effect. |
Actiq has an average rating of 9.1 out of 10 from a total of 16 ratings on Drugs.com. 93% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See also: Subsys side effects in more detail. |
Commonly reported side effects include:
See also: fentanyl side effects in more detail. |
Common side effects include:
See also: Actiq side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all fentanyl prices |
View all Actiq prices and generic prices |
||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other fentanyl brands include: Actiq, Duragesic, Fentanyl Transdermal System, Fentora, Lazanda | Actiq, Duragesic, Fentanyl Transdermal System, Fentora, Lazanda, Subsys | Other fentanyl brands include: Duragesic, Fentanyl Transdermal System, Fentora, Lazanda, Subsys | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
8.7 hours |
8.7 hours |
8.7 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 578 drugs are known to interact with Subsys:
|
A total of 578 drugs are known to interact with fentanyl:
|
A total of 578 drugs are known to interact with Actiq:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
January 04, 2012 |
N/A |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.